Work

Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing

Year: 2026
Type: article
Abstract: Hematopoietic stem cells (HSCs) occupy the apex of the blood cell hierarchy, and artificial intelligence (AI) is fundamentally reshaping how their biology is decoded from normal self-renewal to malignant transformation and clinical transplantation. Trajectory inference algorithms applied to single-cell multi-omics have resolved continuous HSC differentiation with lineage priming detectable at the single-cell level, while convolutional neural networks trained on chromatin imaging predict HSC biological age and detect epigenetic rejuvenation signatures. In leukemic stem cell (LSC) biology, multi-omics deep learning models map treatment-resistant quiescent LSC subclones, detect minimal residual disease with an area under the curve of 0.97 and predict venetoclax sensitivity in LSC-enriched niches. Deep learning also maps myeloma stem cell niche interactions and spatial heterogeneity in bone marrow biopsies. Virtual screening powered by AI speeds up LSC-targeted drug discovery, and reinforcement learning and digital twin models improve ex vivo HSC manufacturing and industrial-scale production of chimeric antigen receptor-T cells. In transplantation, natural language processing extraction and hybrid models classify risk for graft-vs -host disease into clinically relevant subgroups. Overall, top-performing AI models serve as computational surrogates for stemness biology but challenges in dataset diversity, interpretability and regulatory compliance need to be addressed before being used in a clinical setting.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7164989671
FWCI:
Cites: 113
Cited by:
Related to: 10